公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2011 | Low ratio of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol-glucuronides (NNAL-Gluc)/free NNAL increases urothelial carcinoma risk | Chung C.-J.; Lee H.-L.; Yang H.-Y.; Lin P.; YEONG-SHIAU PU ; Shiue H.-S.; Su C.-T.; Hsueh Y.-M. | Science of the Total Environment | 13 | 10 | |
2016 | Patients with urothelial carcinoma have poor renal outcome regardless of whether they receive nephrouretectomy | Hung P.-H.; Tsai H.-B.; KUAN-YU HUNG ; Muo C.-H.; Chung M.-C.; Chang C.-H.; Chung C.-J. | Oncotarget | 2 | 2 | |
2008 | Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility | Huang Y.-K.; YEONG-SHIAU PU ; Chung C.-J.; Shiue H.-S.; Yang M.-H.; Chen C.-J.; Hsueh Y.-M. | Food and Chemical Toxicology | 54 | 45 | |
2013 | Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma | Wu C.-C.; Huang Y.-K.; Chung C.-J.; CHAO-YUAN HUANG ; YEONG-SHIAU PU ; Shiue H.-S.; Lai L.-A.; Lin Y.-C.; Su C.-T.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 30 | 24 | |
2020 | Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma | Chung C.-J.; Bao B.-Y.; Lin Y.-C.; Huang Y.-L.; Shiue H.-S.; Ao P.-L.; YEONG-SHIAU PU ; CHAO-YUAN HUANG ; Hsueh Y.-M. | Scientific Reports | 10 | 7 | |
2008 | Polymorphisms in cell cycle regulatory genes, urinary arsenic profile and urothelial carcinoma | Chung C.-J.; Huang C.-J.; YEONG-SHIAU PU ; Su C.-T.; Huang Y.-K.; Chen Y.-T.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 24 | 20 | |
2010 | Polymorphisms in one-carbon metabolism pathway genes, urinary arsenic profile, and urothelial carcinoma | Chung C.-J.; YEONG-SHIAU PU ; Su C.-T.; Chen H.-W.; Huang Y.-K.; Shiue H.-S.; Hsueh Y.-M. | Cancer Causes and Control | 49 | 46 | |
2011 | The polymorphisms of P53 codon 72 and MDM2 SNP309 and renal cell carcinoma risk in a low arsenic exposure area | CHAO-YUAN HUANG ; Su C.-T.; Chu J.-S.; Huang S.-P.; YEONG-SHIAU PU ; Yang H.-Y.; Chung C.-J.; Wu C.-C.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 27 | 24 | |
2011 | Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma | Chung C.-J.; YEONG-SHIAU PU ; Chen Y.-T.; Su C.-T.; Wu C.-C.; Shiue H.-S.; CHAO-YUAN HUANG ; Hsueh Y.-M. | Science of the Total Environment | 16 | 14 | |
2015 | Risk of Endometrial Cancer in Women with Pelvic Inflammatory Disease | Yang T.-K.; Chung C.-J.; Chung S.-D.; Muo C.-H.; Chang C.-H.; CHAO-YUAN HUANG | Medicine (United States) | 21 | 20 | |
2012 | Sex Differences in the Development of Malignancies among End-Stage Renal Disease Patients: A Nationwide Population-Based Follow-Up Study in Taiwan | Chung C.-J.; CHAO-YUAN HUANG ; Tsai H.-B.; Muo C.-H.; Chung M.-C.; Chang C.-H.; Huang C.-C. | PLoS ONE | 21 | 17 | |
2020 | Subsequent risk of acute urinary retention and androgen deprivation therapy in patients with prostate cancer: A population-based retrospective cohort study | Yang T.-K.; Wu C.-C.; Chang C.-H.; Muo C.-H.; CHAO-YUAN HUANG ; Chung C.-J. | Medicine (United States) | 0 | 0 | |
2008 | Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area | Chung C.-J.; Huang C.-J.; YEONG-SHIAU PU ; Su C.-T.; Huang Y.-K.; Chen Y.-T.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 70 | 61 | |
2007 | Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure | YEONG-SHIAU PU ; Yang S.-M.; Huang Y.-K.; Chung C.-J.; Huang S.K.; Chiu A.W.-H.; Yang M.-H.; Chen C.-J.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 123 | 113 | |
2012 | Urinary total arsenic and 8-hydroxydeoxyguanosine are associated with renal cell carcinoma in an area without obvious arsenic exposure | CHAO-YUAN HUANG ; Su C.-T.; Chung C.-J.; YEONG-SHIAU PU ; Chu J.-S.; Yang H.-Y.; Wu C.-C.; Hsueh Y.-M. | Toxicology and Applied Pharmacology | 22 | 18 |